Lyra Therapeutics, Inc.
LYRADelisted Apr 20, 2026- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001327273
Lyra Therapeutics, Inc. was delisted on Apr 20, 2026; its insiders filed their last Form 4 on May 15, 2026; 23 institutions reported holding it in 13F filings for Q4 2025, worth $747.3K in total; no superinvestor held it.
13F holders, Q1 2022
Institutional positions in Lyra Therapeutics, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 28
- −6 vs. Q4 2021
- Shares held
- 5.02M
- −110.8K (−2.2%) vs. Q4 2021
- Total value
- $20.2M
- −$2.19M (−9.8%) vs. Q4 2021
- New holders
- 2
- 6 more added
- Sold out
- 8
- 8 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LYRA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 1 | $51.1K |
| Q4 2025 | 23 | $747.3K |
| Q3 2025 | 26 | $2.93M |
| Q2 2025 | 30 | $4.42M |
| Q1 2025 | 57 | $3.23M |
| Q4 2024 | 54 | $5.54M |
| Q3 2024 | 62 | $8.36M |
| Q2 2024 | 51 | $9.06M |
| Q1 2024 | 79 | $283.4M |
| Q4 2023 | 60 | $222.0M |
| Q3 2023 | 45 | $124.8M |
| Q2 2023 | 39 | $138.4M |
| Q1 2023 | 31 | $38.1M |
| Q4 2022 | 37 | $59.9M |
| Q3 2022 | 38 | $96.0M |
| Q2 2022 | 38 | $108.9M |
| Q1 2022 | 28 | $20.2M |
| Q4 2021 | 34 | $22.4M |
| Q3 2021 | 37 | $60.8M |
| Q2 2021 | 46 | $56.0M |
| Q1 2021 | 50 | $87.6M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Lyra Therapeutics, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Group AG | 18 | $0 | 0.00% | −4,052−99.6% | Reduced |
| Royal Bank of Canada | 77 | $0 | 0.00% | 00.0% | Unchanged |
| Investors Research Corp | 15 | $0 | 0.00% | 00.0% | Unchanged |
| Prospera Financial Services Inc | 100 | $0 | 0.00% | +100 | New |
| TD Waterhouse Canada Inc. | 200 | $830 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 500 | $2.00K | 0.00% | −734−59.5% | Reduced |
| US Bancorp | 500 | $2.00K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 537 | $2.00K | 0.00% | 00.0% | Unchanged |
| Laurel Wealth Advisors LLC | 500 | $2.00K | 0.00% | 00.0% | Unchanged |
| Worth Asset Management, LLC | 650 | $3.00K | 0.00% | +650 | New |
| Close Asset Management Ltd | 7,000 | $30.0K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 7,759 | $31.0K | 0.00% | +6,910+813.9% | Added |
| Morgan Stanley | 8,085 | $33.0K | 0.00% | −1,346−14.3% | Reduced |
| Renaissance Technologies LLC | 17,500 | $70.0K | 0.00% | −34,500−66.3% | Reduced |
| BlackRock Inc. | 19,006 | $77.0K | 0.00% | +733+4.0% | Added |
| Two Sigma Advisers, LP | 20,000 | $80.0K | 0.00% | −36,700−64.7% | Reduced |
| Geode Capital Management, LLC | 37,464 | $150.0K | 0.00% | +1,446+4.0% | Added |
| Boothbay Fund Management, LLC | 38,516 | $155.0K | 0.01% | 00.0% | Unchanged |
| Ensign Peak Advisors, Inc | 39,167 | $157.0K | 0.00% | 00.0% | Unchanged |
| Pentwater Capital Management LP | 60,000 | $241.0K | 0.00% | −11,313−15.9% | Reduced |
| Bridgeway Capital Management, LLC | 66,900 | $269.0K | 0.01% | 00.0% | Unchanged |
| Bank of America Corp | 82,200 | $330.0K | 0.00% | −1,640−2.0% | Reduced |
| Millennium Management LLC | 112,707 | $453.0K | 0.00% | −40,227−26.3% | Reduced |
| Clearline Capital LP | 119,924 | $482.0K | 0.07% | +55,062+84.9% | Added |
| Vanguard Group Inc | 218,753 | $879.0K | 0.00% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 422,338 | $1.70M | 0.52% | +27,802+7.0% | Added |
| Pura Vida Investments, LLC | 520,544 | $2.09M | 0.25% | +3,300+0.6% | Added |
| Perceptive Advisors LLC | 3,222,560 | $13.0M | 0.27% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −17,731−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −13,252−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −13,127−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −11,200−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −10,655−100.0% | Sold out |
| Soleus Capital Management, L.P. | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| CoreCap Advisors, LLC | 0 | $0 | 0.00% | −125−100.0% | Sold out |
| Koshinski Asset Management, Inc. | 0 | $0 | 0.00% | −200−100.0% | Sold out |